![](https://i0.wp.com/sitn.hms.harvard.edu/wp-content/uploads/2020/08/cancer-cells.jpg?resize=870%2C773&ssl=1)
Breaking Down Instead of Silencing: A Step Forward in a New Class of Drugs
Biologists at Stanford University have developed the LYTAC, a new class of drug that might be the future of therapeutics due to its ability to breakdown previously un-accessible proteins on cell walls and its adaptability. Continue reading Breaking Down Instead of Silencing: A Step Forward in a New Class of Drugs